Search research articles
Contact Us
Filters
Showing results (271-280 of 385) with videos related to
Page
of 39
Sort By:
Haematologica
|
June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
Norbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
International Journal of Environmental Research and Public Health
|
January 8, 2023
Assessing Differences in Attitudes toward Occupational Safety and Health Measures for Infection Control between Office and Assembly Line Employees during the COVID-19 Pandemic in Germany: A Cross-Sectional Analysis of Baseline Data from a Repeated Employee Survey
Jana Soeder, Anna T Neunhöffer, Anke Wagner, et al.
British Journal of Haematology
|
December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial
Birte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia
Birte Friedrichs, Sandra Siegel, Marita Kloess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma
Gerhard Held, Niels Murawski, Marita Ziepert, et al.
Psychiatric Rehabilitation Journal
|
November 4, 2021
Fit for purpose: Conception and psychometric evaluation of developmentally appropriate measures to assess functional recovery in first-episode psychosis across geo-cultural contexts
Srividya N Iyer, Ashok Malla, Aarati Taksal, et al.
The Lancet. Oncology
|
May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial
Bertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Rafael F Duarte, Carmen Canals, Francesco Onida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
Philip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Blood
|
June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR
Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
Page
of 39
Search research articles
Search
Showing results (271-280 of 385) with videos related to
Sort By:
Page
of 39
Haematologica
|
June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
Norbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
International Journal of Environmental Research and Public Health
|
January 8, 2023
Assessing Differences in Attitudes toward Occupational Safety and Health Measures for Infection Control between Office and Assembly Line Employees during the COVID-19 Pandemic in Germany: A Cross-Sectional Analysis of Baseline Data from a Repeated Employee Survey
Jana Soeder, Anna T Neunhöffer, Anke Wagner, et al.
British Journal of Haematology
|
December 7, 2018
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial
Birte Friedrichs, Maike Nickelsen, Marita Ziepert, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia
Birte Friedrichs, Sandra Siegel, Marita Kloess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma
Gerhard Held, Niels Murawski, Marita Ziepert, et al.
Psychiatric Rehabilitation Journal
|
November 4, 2021
Fit for purpose: Conception and psychometric evaluation of developmentally appropriate measures to assess functional recovery in first-episode psychosis across geo-cultural contexts
Srividya N Iyer, Ashok Malla, Aarati Taksal, et al.
The Lancet. Oncology
|
May 16, 2014
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial
Bertram Glass, Justin Hasenkamp, Gerald Wulf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Rafael F Duarte, Carmen Canals, Francesco Onida, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
Philip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Blood
|
June 19, 2004
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR
Matthias Ritgen, Stephan Stilgenbauer, Nils von Neuhoff, et al.
Page
of 39